Glycobiology Conference | Glycobiology 2019

Theme: A path to the emerging trends in the field of glycobiology research

Glycobiology Asia 2019

Conference Program

Renowned Speakers

Julian M Menter
Morehouse School of Medicine
USA

Myron R Szewczuk
Queenâ€™s University
Canada

Robert Engel
Queens College, USA
UK

Clifford Lingwood
University of Toronto
Canada

Miki Hara-Yokoyama
Tokyo Medical and Dental University
Japan

Michio Kurosu
University of Tennessee Health Science Center
USA

Kyoko Shinzawa-Itoh
Hyogo University
Japan

Joon Kim
Korea University
South Korea

Glycobiology Asia 2019

Conference Series llc Ltd will take the privilege to declare the inauguration of its “8th Asia Pacific Glycobiology Congress "going to be held in Tokyo, Japan during May 10-11, 2019 . The subject of the conference is “A path to the emerging trends in the field of glycobiology research”.

Glycobiology Asia 2019 anticipates international Organizing Committee Members, international keynote speakers, oral presentations by renowned speakers, Poster presentations, Video Presentations, e-poster presentations, Workshops and Exhibitions with delegates all across the globe. Glycobiology Asia 2019 is a platform for the worldwide campaign of Research work in an efficient way.

Importance and Scope

Glycobiology basically involves all about the study of assembly, function and biology of carbohydrates, biosynthesis related to sugars and saccharides. Recently Glycobiology is quickly emerging as a preliminary arena of concern for biomedical and bimolecular research around the world. It is the developing field in the area of research related to biomolecules which mainly includes the study of different metabolic pathways, along with the prediction of the various structures of glycans related biomolecules and many others etc.

Glycobiology Asia 2019 meeting will be organized by Conference Series llc Ltd which is consisted of 3000+ Global Events with more than 1000+ Conferences, 1200+ Symposiums and 1200+Workshops on different fields of Medical, Pharmaceutical, Clinical, Engineering, Science, Technology and Business. Glycobiology Asia 2019 is going to conduct an analytical research on the topics of recent advancements in the field of Glycobiology and to extend the most current innovations and arrays in the arena of Glycobiology and Glycochemistry, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, Metabolomics, Bioinformatics, Genomics, structural biology and many more.

The conference is going to bring together glycobiologists, scientists, molecular biologists, biochemists, industrial experts, delegates, sponsors and related exhibitors from all around the world to the marvellous city of Tokyo, Japan. The conference theme emphases on "A path to the emerging trends in the field of glycobiology research".

Glycobiology Asia 2019 is an ideal platform for experts, world-class professors, and glycobiologists to discuss an approach for glycobiology and its related research areas. The conference will impact an attractive moment to interact with professionals in the research field and therefore it takes the pride in opening a gate to meet young researchers and potential speakers where they can present their novel research and contributions in the field of glycobiology and its related fields.

Why to attend?

Glycobiology Asia 2019 is the most ideal platform for professionalists, young researchers, Industrialists to interact with the global participants and to interchange the knowledge and research work in the diverse field of Glycobiology and its related fields. Glycobiology Asia 2019 is intended to come across with all the prominent and renowned lecturers, research professionals from all around the world with delegates, exhibitors, and industry experts and workshop symposiums.

Glycobiology Asia 2019 focuses on:

Professional development

Networking

To present your work and learn from others work

To learn new things and new technologies and products in the field of glycobiology

To meet representatives from funding agencies

Know and be known

Meet your next industry collaboration

Why in Tokyo, Japan?

Tokyo, Japan is the hub of glycobiology research. Tokyo is emerging rapidly in the field of glycobiology. Glycobiology Asia 2019 is going to be a perfect platform for the young researchers, student fellows, biochemists, glycobiologists of Tokyo, Japan to come together under one platform in order to exchange their research ideas about glycans, exchanging ideas about it and thus, contributes to the propagation of knowledge for the benefit of both the academia and business. The conference is going to bring together glycobiologists, scientists, molecular biologists, biochemists, doctors, industrial experts, delegates, sponsors and related exhibitors from all around the world to the marvellous city of Tokyo, Japan. This event brings together eminent researchers and associates to explore the emerging field. We bring together Knowledge, creative, and technology leaders from the Biology industry for the most current and relevant discussions. Glycobiology Asia 2019 will provide the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Glycobiology and this conference will contribute towards the future advancements in the arena of Glycobiology in the charming city of Tokyo, Japan.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations

Poster Display

Symposium hosting (4-5 member teams)

Workshop organizing

For Universities, Associations & Societies:

Association Partnering

Collaboration proposals

Academic Partnering

Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)

Young Researcher Forum (YRF Award to the best presenter)

Student Attendee

Group registrations

For Business Delegates:

Speaker Presentations

Symposium hosting

Book Launch event

Networking opportunities

Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths

Sponsorships opportunities

Product launch

Workshop organizing

Scientific Partnering

Marketing and Networking with clients

Target Audience:

Glycobiologists

Scientists and Researchers

Biochemistry Associations and Societies

Biochemists

Biotechnologists

Molecular biologists

Directors/Managers & Business Delegates

Biochemistry Experts

Director of Laboratories, Universities, Industries,

Medical Colleges

Research Training Institutes

Pharma Companies

Principal Investigators

Post-Doctoral Fellows

Research and Diagnostic Laboratories

Clinical Fellows

Students

Biomedical Research companies.

Conference Highlights:

Opportunity to attend the presentations delivered by eminent scientists from all over the world
Selected contributions will be published in following Conference Series llc LTD Journals:-

Journal of Glycobiology

Journal of Glycomics & Lipidomics

Biochemistry & Analytical Biochemistry

Participation in sessions on specific topics on which the conference is expected to achieve progress
Global networking: In transferring and exchanging Ideas
Share your excitement in promoting your skills in the field of designing
Conference brings together Scientific Researchers, Business Entrepreneurs and Industry Developers

Benefits of attending:

All accepted abstracts will be published in the supporting journals of the conference and Conference Book Proceedings.
Each abstract will receive a DOI number provided by Cross Ref
Opportunity to conduct Workshop with your team members
One to One Interaction with Keynote Speakers, OCM and Eminent personalities for the future course of work.
Opportunity to chair a session.
Certification by the organizing committee.
Individual keynote Page will be created to get more visibility for your scientific research.
Huge Benefits on Group Registration and much more.
Glycobiology meetings provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings. B2B Meetings are a quick and easy way to meet potential cooperation partners.
The attending delegates include Editorial Board Members of related International Journals.
This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists
Strengthen and share knowledge in your area of expertise and learn about topics of cancer control and global health that will complement your field of work through your encounters with the global medical Glycobiologists, molecular biologists, biochemists and be a part of these inspiring sessions.

Track-01: Glycobiology: It’s Role in Human Health

Glycobiology research plays a pivotal role from the perspective of human health. In order to maintain and advance the recognition of important glycobiological features and the application of glycans and glyco-engineering strategies in the design of novel treatments to improve human health, the study on recent advancements in glycobiology is of utmost important Scientists at the University of Georgia have received a five-year, $10.4 million funding from the National Institutes of Health to support the National Center for Biomedical Glycomics, a association of UGA faculty and staff functioning to improve new technologies for the analysis of glycans . Experts now identify that glycans play critical roles in cell regulation, human health and disease progression. The experts at the Complex Carbohydrate Research Center have experience and knowledge that make us a world leader in this field, and are creating tools that are the basis for the next generation of diagnostics and treatments.

8th Glycobiology World Congress, September 23-24, 2019, Barcelona, Spain | 4th Glycobiology World Congress, September 17-19, 2018 | Rome, Italy; 3rd Glycobiology World Congress, June 26-28, 2017, London, UK | 2nd Glycobiology World Congress; August 29-31, 2016, Atlanta, USA | 5th International Conference on Glycobiology & Glycoproteomics, August 27-28, 2018, Toronto, Canada | Glycobiology, Lipid and Protein Meeting 2019, Oct 30-31, 2019, Tokyo, Japan | ICGG 2018: 20th International Conference on Glycobiology and Glycosciences, May 24 - 25, 2018, Montreal, Canada | 29th Joint Glycobiology Meeting 2018, October 21-23 ,2018, Ghent, Belgium | Society For Glycobiology 2018 Annual Meeting, November 5-8, 2018, New Orleans, Louisiana, USA | Joint Symposium on Translational Glycobiology of Human Stem Cells, November 12 2018, Mexico City | 4th All-Russian Conference on Fundamental Glycobiology, September 23-28,2018, Kirov, Russia | FASEB Science Research Conference Microbial Glycobiology, June 17 – 22,2018,Scottsdale, Arizona, USA

Track-02: Synthesis and Biological Role of Glycans

The biological functions of glycans span the range from those that appear to be relatively subtle, to those that are crucial for the growth, development, functioning, or survival of the organism that produces them. The biological functions of glycans can be divided into two broad groups: (1) the structural and modulatory properties of glycans and (2) the specific identification of glycans by other molecules most commonly, glycan-binding proteins (GBPs). The biological effects of changing glycosylation in numerous structures appear to be extremely variable and unpredictable. A particular glycan can have diverse functions in different tissues or at different intervals in development (organism-intrinsic functions) or in different environmental contexts (organism-extrinsic functions). Methods taken to recognize the biological roles of glycans comprise the inhibition of initial glycosylation, prevention of glycan chain elongation, alteration of glycan processing, genetic elimination of glycosylation sites, enzymatic or chemical deglycosylation of completed chains, and the study of naturally occurring genetic variants and mutants in glycosylation.

Glycobiology, Lipid and Protein Meeting 2019, Oct 30-31, 2019, Tokyo, Japan | ICGG 2018: 20th International Conference on Glycobiology and Glycosciences, May 24 - 25, 2018, Montreal, Canada | 29th Joint Glycobiology Meeting 2018, October 21-23 ,2018, Ghent, Belgium | Society For Glycobiology 2018 Annual Meeting, November 5-8, 2018, New Orleans, Louisiana, USA | Joint Symposium on Translational Glycobiology of Human Stem Cells, November 12 2018, Mexico City | 4th All-Russian Conference on Fundamental Glycobiology, September 23-28,2018, Kirov, Russia | FASEB Science Research Conference Microbial Glycobiology, June 17 – 22,2018,Scottsdale, Arizona, USA | 8th Glycobiology World Congress, September 23-24, 2019, Barcelona, Spain | 4th Glycobiology World Congress, September 17-19, 2018 | Rome, Italy; 3rd Glycobiology World Congress, June 26-28, 2017, London, UK | 2nd Glycobiology World Congress; August 29-31, 2016, Atlanta, USA | 5th International Conference on Glycobiology & Glycoproteomics, August 27-28, 2018, Toronto, Canada

Track-03: Evolution of Glycan Diversity

An enzymatic process called as glycosylation facilitate glycans to attach a wide variety of biological molecules through to enhance their role. Glycans are found in archaea, bacteria and eukaryotes, and their varied roles contribute to maintain physical and structural integrity, formation of extracellular matrix, signal transduction, protein folding and information exchange between cells (and pathogens). Glycans are the major molecule on the cell surface and function as the primary point of interaction between a cell and other cells, the extracellular matrix and pathogens. The intensified evolutionary pressure of being at the front lines of cellular collaboration and conflict most likely led to the modification of glycans. Glyco-epitope diversity augments the function of glycans in the group of debilitating and life-shortening disorders known as congenital muscular dystrophy, or CMD. Both ECM and the membrane proteins are highly glycosylated, and O-glycans are vital for proper ECM function and communication between cells and the ECM. Numerous Glycoepitomics forms of CMD are known to result from dysfunctional O-glycosylation of membrane and ECM proteins; however, one-third of CMDs arise from an unknown genetic etiology.

Track-04: Glycan Catabolism and Systemic Physiology

The human intestine hosts trillions of bacteria that directly influence human health. The majority of gut microbes play a significant role in nutrition by digesting host-indigestible complex glycans into short-chain fatty acids. Development of the mesh-like peptidoglycan (PG) sacculus located between the bacterial inner and outer membranes (OM) is tightly regulated to ensure maintain cell shape and cellular integrity. Cytoskeletal elements focus on location and activity of PG synthases from inside the cell, but exact spatiotemporal regulator over this process is poorly understood. Glycan catabolism contains metabolic pathway maps for glycans. Some of them contain a substitute representation of glycan biosynthesis or degradation, called the glycan structure map.

Track-05: Glycobiology and Glycochemistry

Glycochemistry and Glycobiology are the two main intertwined areas of Glycosciences, dealing with various aspects of glycans, including carbohydrate structure, biochemistry, biological functions and applications. This is required in order to maintain and advance the recognition of important glycobiological features and the application of glycans and glyco-engineering strategies in the design of novel treatments to improve human health. The glycans (carbohydrates) form a varied cluster of biomolecules which play active parts in most biological processes. The arena of structural glycobiology involves of the structures of the glycans themselves, the proteins which interact with them and the nature of the interactions between the two. Drug targeting is an important aspect in order to understand human health and disease, and for development of novel therapeutic strategies.

Track: 06:Glycomics and Metabolomics

Glycomics is a field in genetics that uses recombinant DNA, DNA sequencing methods and bioinformatics to sequence, assemble and analyze the function and structure of glycans along with the genomes. Metabolomics is concerned with the systematic study of the biological products or metabolites that cells and organisms produce. Certainly, most human metabolomics reports published today, even those developing the recent and most sensitive LC-MS/MS technologies, typically succeed in recognizing or characterising fewer than 100 compounds. This comprises the human cerebrospinal fluid metabolome: the human saliva metabolome and the human serum metabolome.

Track-07: Glycans in Diseases and Therapeutics

Glycomedicine functions a pivotal role in cell-cell adhesion i.e. a tool utilized by cells of the immune system through sugar-binding proteins called lectins, which identify specific carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play foremost roles in numerous biological phenomena as well as in various pathophysiological processes. Many researchers have now understood that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is a significant field of research and sometimes they require a glycobiology method to be exploited.

Track-08: Mass Spectrometry Analysis

Mass spectrometry (MS) is a vital diagnostic method that ionizes chemical species and sorts the ions based on their mass-to-charge ratio. A mass spectrum is a graphical plot of the ion signal as a function of the mass-to-charge ratio during experimental analysis. These spectra are then exploited to regulate the primary or isotopic name of a sample for observations, the masses of particles and of various molecules, and to elucidate the chemical structures of desired molecules, such as glycopeptides, biomolecules, and other chemical compounds.

Track-09: Glycoconjugates, Glycomics and Transcriptomics

Glycomics is a branch in genetics that uses DNA sequencing methods, recombinant DNA, and bioinformatics to sequence, assemble and identify the role and arrangement of glycans along with the genomes. Transcriptomics is a comparatively new branch of science that is concerned with the organised study of the chemical products or metabolites that cells and organisms produce. Certainly, most human metabolomics reports published today, even those developing the recent and most sensitive LC-MS/MS technologies, typically succeed in recognizing or characterising fewer than 100 compounds. This comprises the human cerebrospinal fluid metabolome: the human saliva metabolome and the human serum metabolome. This resembles to fewer than 1% of the recognized human metabolome.

Track-10: Glycobiology in Lipid Science

Glycans are constituents of numerous bio-therapeutic agents, extending from natural products to molecules established on rational design to recombinant glycoproteins. The glycan constituents of these agents can be important factors of their biological activity and therapeutic efficacy. Glycobiology and Biochemistry comprises a multidisciplinary branch of carbohydrate-binding proteins (lectins), glycolipids and some other plant proteins that are capable of interacting with endogenous or foreign (macro) molecules.

Track-11: Glycans in Vaccine Development

Glycans are at the core of many disorders and diseases generating the chance of exploiting them for therapeutic and diagnostic purposes. There are many biochemical paths and diseases in which glycans are intricately involved. Evaluating the huge potential and the capacity that glycobiology holds, many pharma and biotech companies have already started assigning their R&D budget to it. Currently, with our drug resource fast depleting against drug resistant and mutant pathogens, glycobiology hold an intact source of new candidate drugs.

Track-12: Glycans in Structural and Computational Systems Biology

Glycan arrangements cannot be described by a simple linear one-letter code as each pair of monosaccharides can be linked in several ways and branched structures can be formed. Limited bioinformatics algorithms established for genomics or proteomics can be directly modified for glycomics. The growth of algorithms, which allow a quick, automatic analysis of mass spectra to classify glycan structures, is presently the most active field of research. The growth and use of informatics tools and databases for glycobiology and glycomics research has increased significantly in recent years. In terms of bioinformatics in glycobiology, there are several paths of research that are currently in growth.

Track-13: Structural Bioinformatics and Proteomics

Glycobiology along with the field of proteomics, principally the use of mass spectrometry analysis to protein samples, is well-established and growing speedily. Proteomics reports along with the glycans produce large capacities of raw experimental data and inferred biological consequences. To enable the distribution of these data, federal data sources have been established that make the information and results available to proteomics researchers and biologists alike. Experimental study of proteomics data sources emphases completely on freely-available, centralized data resources that distribute or store experimental mass spectrometry data and results.

Track-14: Glycosciences and Monosaccharides

Glycobiology is the study of the arrangement, biosynthesis and biology of saccharides that are extensively dispersed in nature. Sugars or saccharides are essential constituents of all living things and features the several roles they play in biology and are researched in various medical, biochemical and biotechnological fields. The study of glycan structures is also complexed by the absence of a direct pattern for their biosynthesis, conflicting to the case with proteins where their amino acid sequence is identified by their corresponding gene.

Track-15: Glycopathology: Glycans in Cancer

Starches are principally considered as main source of essential resources and energy for living beings. Current modern study’s in this zone has dedicated mainly on simple basic sugars and homopolysaccharides such as, starch, cellulose, glycogen, and chitin. During the last few decades, the scientists have changed their concentration on complex forms like carbohydrates, especially proteoglycans, glycolipids and glycoproteins which are collectively denoted to as glycoconjugates that displays the possible recognition markers in the biological system which also relays to other biomedical and clinical fields. The roles of glycans and glycoconjgates in cancer have been highlighted, because minor changes in glycosylation can enormously control the whole pathway and mechanisms of cancer, which leads to an indication as a biomarker development leading to various therapeutics developments in cancer research.

Track-16: Glycobiology and Biotechnology

The increasing importance of glycobiology and carbohydrate chemistry in modern biotechnology and the pharmaceutical industry is tremendously increasing. The starches of therapeutic recombinant glycoproteins have significant roles in determining their pharmacokinetic properties. Significant biological interactions and biological functions mediated by glycans are also being directed for therapeutic manipulation in vivo. Examples of carbohydrate-based therapeutics in development include inhibitors of microbial pathogens and their toxins, cancer vaccines, and drugs designed to suppress the immune system for treatment of inflammation and transplant rejection.

Track-17: Glyconeurobiology: Glycans in Neuroscience

Sugar rich molecules like including glycolipids, glycoproteins, and proteoglycans in the nervous system have significant roles during growth, redevelopment and synaptic plasticity. The structural diversity of the carbohydrate moieties renders them ideally suited as stage-specific biomarkers for numerous cell types leading to mediate interactions between recognition molecules, thereby contributing to the formation of a complex molecular structure at the cell surface and in the extracellular matrix of the cell. The exceptional structural diversity of glycan chains and related moieties allows for huge advanced possibilities that can leads to cell interactions along with cell matrix interactions.

Track-18: Glyco Immunology

Sugars were very significant in the early history of immunology in defining the identity of antigens which are identified by antibodies. So the skill of these antibodies to uniquely identify glycans and carbohydrate related molecules was exploited in studies defining the size of the antigen-binding site. Many carbohydrate-binding proteins, or lectins, have been recognized on the surfaces of immune cells which intensify the significance of sugars in both innate and adaptive immune responses in development of modern vaccines and immunological therapeutics. Currently glycobiologists and immunologists are now collaborating widely to explore this crucial field in the area of immunobiology.

Track-19: Glycans in Drug Design

Glycans are constituents of many bio-therapeutic agents, extending from natural products to molecules based on rational design to recombinant glycoproteins. The glycan constituents of these agents can be significant factors of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology encompasses a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids and some other plant proteins that are capable of relating with endogenous or foreign (macro) molecules. The importance of the research is on protein-carbohydrate interaction and their contribution in signalling processes in plants or in plant protection. Based on the generated fundamental awareness new approaches are being developed to shield crop plants against pests and diseases.

Track-20: Recent Advances in Glycobiology

Generally glycans are vital constituents of various bio therapeutic agents, conflicting from natural products to molecules based on various rational designs to recombinant glycoproteins and glycoconjugates. The glycan constituents of these agents can be significant elements of their biological activity and therapeutic ability. Modern patenting of novel therapeutics typically requires elucidations of the arrangement of matter in the claimed molecule for approval. Many significant progresses can be seen in the areas of imaging, structure prediction technologies and advancement of hybrid methods to recognise the structure and role of carbohydrates and proteins.

Importance and Scope:

The experts have predicted the Global Biochemistry Analyzers market to raise at a CAGR of 4.50 percent over the period of 2012-2016.An understanding to the associated significance of biochemistry study shows a development of about $ 3,200 Million in the year 2017 to about $ 4,700 Million by the end of 2024. This signifies a CAGR of 5.5% over the forecast period, with a balanced growth during the next four years and posts a CAGR of over 6% by 2021.However; the negative impact of global recession could cause a challenge to the growth of this market.

The information, the Global Biochemistry Analyzers Market Report, has been prepared established on an in-depth market analysis with contributions from industry experts. The report includes the Americas, and the EMEA and APAC regions; it also comprises the Global Biochemistry Analyzers market landscape and its development prospects in the upcoming years. The report also comprises a symposium of the key traders working in this market.

Glance at Market of Glycobiology:

The scientific development in biochemistry and molecular biology has played an important role in the growth of the glycobiology market during the last era. Also, the enhancements in analytical tools, and documents processing and analysis software have added considerably in the progression of the glycobiology arena. The existence of research finance and government funding for conducting research and commercialization of the products in the glycobiology market is the main driver for the development of this market. Glycobiology knowledge is used widely in biomarker innovation and drug assessment. Thus, the quick growth experienced by pharmaceutical and biotechnology businesses is supporting the development of the glycobiology market.The worldwide glycobiology market was esteemed at $512.38 million in 2014 and poised to grow at a CAGR of 12.62% between 2012 and 2019, to reach $928.11 million in 2019. The quick increase in research and growth expenditure by pharmaceutical and biotech companies, and increased capital in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019). Geographic study discloses that North America accounted for the major portion of the international glycomics market in 2014, due to growing capital for proteomics and glycomics study. For example, in August 2013, the National Institutes of Health (NIH) delivered $5.5 million to the National Center for Functional Glycomics (NCFG) for research into the documentation of glycans and complex carbohydrates using glycan microarrays. Likewise, in 2011, the University Of Nevada School Of Medicine received $10 million for glycobiology research from NIH. The major companies in this market comprise Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S), Agilent Technologies (U.S.)

Why to attend?

ENCOUNTER YOUR TARGET MARKET with participants from around the globe concentrated on knowledge about Biological research and growing market, this is your only best opportunity to grasp the largest assembly of members from the scientific community. Conduct demonstrations, distribute information, meet with current and potential customers, and make a splash with a novel product line, and receive name appreciation at this 2-day event. World-renowned presenters, the most new methods, strategies, and the newest updates in Glycobiology growing market are hallmarks of this conference.

Be Part of it!

• This conference concentrating on all the key features in the fields of Glycobiology and its associated research.

• It would be constructive for all the students who ever enthusiastic to move in into research to the respective fields.

• As bringing the main research to the market and making it to efficacy are major focus for all the companies, this conference would be chance for the individuals in the particular fields.

Major Glycobiology Associations around the Globe

Glyconet Glycobiotechnology Network
Glycoscience Graduate School
Mizutani Foundation for Glycoscience
The Japanese Society of Carbohydrate Research
Alberta Glycomics Centre
Copenhagen Center for Glycomics
CKSP: Center of Know-how for Sugars and Polysaccharides, Ben-Gurion University
Laboratory of Carbohydrate Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Science
Glycoprotein Structure/Function Group, Birkbeck College
Oxford Glycobiology Institute
Centre for Glycobiology, University of Liverpool
IBS: Institut de Biologie Structurale
Glycoscience Team, National Centre for Biomedical Engineering Science, National University of Ireland, Galway
Glycosciences Laboratory
Oxford Glycobiology Institute
Glycobiology Group
Glycotechnology Core Resource
Glycobiology Research and Training Center
Glycomics Center
Heparin Home Page, Rensselaer Polytechnic Institute
Resource for Integrated Glycotechnology
Institute of Molecular Biomembrane and Glycobiology

Major Companies:

Abbott Laboratories, Inc. (USA)
Novartis (USA)
Abaxis Inc. (USA)
Danaher Corp. ((USA)
HUMAN GmbH (Germany)
Hitachi High-Technologies Corp.
Medica Corp. (USA)
Mindray Medical International Ltd. (China)
Nova Biomedical Corp. (USA)
Ortho-Clinical Diagnostics Inc. (USA)
Randox Laboratories Ltd.
Roche Holding AG. (Switzerland)
Siemens Healthcare. (Germany)
Thermo Fisher Scientific Inc. (USA)
Pfizer (USA)
Merck (USA)
Novo Nordisk (Denmark)
Amgen (USA)
GlaxoSmithKline (UK)
Bristol-Myers Squibb (USA)
AbbVie (USA)
AstraZeneca (UK)
Mylan (Netherlands)
Amgen Inc., (USA)

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	May 10-11, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View